Post-Acute COVID-19 Syndrome
Conditions
Interventions
This is a three-arm, double-blind, crossover controlled clinical trial. Joint Adjustment Group (AJU): Twelve physically active adults of both sexes, aged 19 to 44 years (DECS: M01.060.116), diagnosed
A04.411
Sponsors
Centro Universitário Augusto Motta
Centro Universitário Augusto Motta
Eligibility
Age
19 Years to 44 Years
Inclusion criteria
Inclusion criteria: Not engage in any physical activity outside of that proposed in the experiment; not be pregnant or breastfeeding; be free of functional limitations that would interfere with the performance of the experimental conditions; be free of any condition that could influence the experimental procedures or the interpretation of the resulting data; not present with abnormal fluid accumulation (edema), particularly in the lower limbs; have no basilar artery impairment that would contraindicate cervical manipulations; include both sexes; aged between 19 and 44 years
Exclusion criteria
Exclusion criteria: Participants must report no history of neurological disorders; must not report any episodes of acute dizziness; and must not present with severe visual impairment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvements are expected in pulmonary capacity, heart rate variability, and blood pressure, assessed via spirometry, heart rate monitor, and digital sphygmomanometer, respectively. Specifically, a minimum 5% increase in respiratory amplitude and R-R interval, along with at least a 5% reduction in systolic blood pressure, are anticipated. All data will be collected immediately before and after the intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected. | — |
Countries
Brazil
Contacts
Public ContactFabiana Sardinha
Centro Universitário Augusto Motta
Outcome results
None listed